FDA Accelerated Approval of First Immunotherapy for treating Metastatic Breast Cancer

Breast Cancer Ireland supports Susan G. Komen – the largest breast cancer organisation in the US – in applauding the decision by the US FDA to provide accelerated approval of a new therapy to treat locally advanced or metastatic triple-negative breast cancer in certain patients.

To read more on this development, please click the link below:



Share This Article